FLUX THROUGH THE DENOVO PYRIMIDINE PATHWAY INVIVO - EFFECT OF N-PHOSPHONACETYL-L-ASPARTATE, A POTENT INHIBITOR OF ASPARTATE-TRANSCARBAMYLASE

被引：0
|
作者：
MONKS, A
ANDERSON, LW
STRONG, J
CYSYK, RL
机构：
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 1983年 / 258卷 / 22期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：3564 / 3569
页数：6
相关论文
共 50 条
  • [31] PLASMA URIDINE LEVELS IN CANCER-PATIENTS TREATED WITH DIPYRIDAMOLE (DP) AND N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    CHAN, TCK
    MARKMAN, M
    HOWELL, SB
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 157 - 157
  • [32] Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non- melanoma skin cancer
    Mahen, Kala K.
    Markley, Lilian
    Bogart, Jolie
    Klatka, Hope
    Krishna, Vijay
    Maytin, Edward V.
    Stark, George R.
    McDonald, Christine
    [J]. EXPERIMENTAL DERMATOLOGY, 2023, 32 (09) : 1485 - 1497
  • [33] A NEW SYNDROME - ASCITES, HYPERBILIRUBINEMIA, AND HYPOALBUMINEMIA AFTER BIOCHEMICAL MODULATION OF FLUOROURACIL WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    KEMENY, N
    SEITER, K
    MARTIN, D
    URMACHER, C
    NIEDZWIECKI, D
    KURTZ, RC
    COSTA, P
    MURRAY, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) : 946 - 951
  • [34] REVERSAL OF TOXICITY AND ANTITUMOR ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTATE BY URIDINE OR CARBAMYL-DL-ASPARTATE INVIVO
    JOHNSON, RK
    [J]. BIOCHEMICAL PHARMACOLOGY, 1977, 26 (01) : 81 - 84
  • [35] C-13 ISOTOPE EFFECT STUDIES OF ESCHERICHIA-COLI ASPARTATE-TRANSCARBAMYLASE IN THE PRESENCE OF THE BISUBSTRATE ANALOG N-(PHOSPHONOACETYL)-L-ASPARTATE
    PARMENTIER, LE
    OLEARY, MH
    SCHACHMAN, HK
    CLELAND, WW
    [J]. BIOCHEMISTRY, 1992, 31 (28) : 6598 - 6602
  • [36] GROWTH INHIBITORY EFFECT OF N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND ITS REVERSAL BY PYRIMIDINES IN MURINE AND HUMAN CULTURED-CELL LINES
    LEYVA, A
    APPEL, H
    MCVIE, JG
    PINEDO, HM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 28 - 28
  • [37] SYNERGISTIC ANTICANCER EFFECT OF 6-METHYLMERCAPTOPURINE (MMPR)6-AMINONICOTINAMIDE(6-AN), AND N-PHOSPHONACETYL-L-ASPARTATE(PALA)
    MARTIN, DS
    STOLFI, RL
    SAWYER, RC
    BALIS, ME
    YOUNG, DW
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 319 - 319
  • [38] EFFECT OF N-PHOSPHONACETYL-L-ASPARTATE AND D-GLUCOSAMINE ON THE INCORPORATION OF 5-FLUOROURIDINE INTO NORMAL-TISSUES AND AN ADENOCARCINOMA IN THE RAT
    ERICHSEN, C
    CHRISTENSSON, PI
    JAKOBSSON, B
    ERIKSSON, G
    YNGNER, T
    JONSSON, PE
    STENRAM, U
    [J]. ANTICANCER RESEARCH, 1987, 7 (01) : 77 - 80
  • [39] NUCLEOTIDE LEVELS IN TUMOR-CELLS AND XENOGRAFTS TREATED WITH COMBINATION DIPYRIDAMOLE (DP) AND N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    CHAN, TCK
    HOWELL, SB
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 244 - 244
  • [40] Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: Carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged
    Smith, KA
    Chernova, OB
    Groves, RP
    Stark, MB
    Martinez, JL
    Davidson, JN
    Trent, JM
    Patterson, TE
    Agarwal, A
    Duncan, P
    Agarwal, ML
    Stark, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1816 - 1821
12345